MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,822,149 | -2.3% | 3,738,100 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $4,934,292 | +192.6% | 3,738,100 | +56.7% | 0.01% | +125.0% |
| Q1 2023 | $1,686,381 | +5.3% | 2,385,600 | +11.7% | 0.00% | -33.3% |
| Q4 2022 | $1,601,700 | -12.9% | 2,135,600 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $1,839,000 | -5.4% | 2,135,600 | +23.0% | 0.01% | +20.0% |
| Q2 2022 | $1,944,000 | -10.3% | 1,735,600 | -10.3% | 0.01% | +25.0% |
| Q1 2022 | $2,168,000 | -30.0% | 1,935,600 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $3,097,000 | -33.9% | 1,935,600 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $4,684,000 | -23.7% | 1,935,600 | 0.0% | 0.01% | -11.1% |
| Q2 2021 | $6,136,000 | -5.9% | 1,935,600 | 0.0% | 0.01% | -10.0% |
| Q1 2021 | $6,523,000 | -5.9% | 1,935,600 | 0.0% | 0.01% | -9.1% |
| Q4 2020 | $6,929,000 | – | 1,935,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 3,215,001 | $4,147,351 | 2.35% |
| Soleus Capital Management, L.P. | 9,677,419 | $12,483,871 | 1.15% |
| 683 Capital Management, LLC | 6,000,000 | $7,740,000 | 0.60% |
| Rubric Capital Management LP | 11,616,120 | $14,984,795 | 0.56% |
| MANGROVE PARTNERS IM, LLC | 5,531,547 | $7,135,696 | 0.54% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $9,500,125 | 0.51% |
| DAFNA Capital Management LLC | 962,513 | $1,241,642 | 0.39% |
| Clearline Capital LP | 3,102,723 | $4,002,512 | 0.34% |
| Rock Springs Capital Management LP | 7,676,481 | $9,902,660 | 0.26% |
| Monaco Asset Management SAM | 595,729 | $768,490 | 0.23% |